Jingyao Zhang
- Cancer Research top 2%
- Cancer-related molecular mechanisms research 12
- Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis 10
- Liver Disease and Transplantation 9
- Molecular Biology top 5%
- RNA modifications and cancer 17
- Epigenetics and DNA Methylation 11
- Pharmacology top 2%
-
- Liver Disease Diagnosis and Treatment 14
- Sepsis Diagnosis and Treatment 10
-
- Hydrogen's biological and therapeutic effects 12
- Co-authors
- Kai QuRuixia CuiYifan JiaJianbin BiChang LiuRunchen MiaoSushun LiuYang Feng
- Partner nations
- ChinaUnited StatesSingapore
In The Last Decade
Jingyao Zhang
174 papers receiving 4.3k citations
Peers
Comparison fields: 5 of 149
- Cancer Research 697
- Hepatology 325
- Molecular Biology 2.1k
- Pharmacology 257
- Complementary and alternative medicine 226
Countries citing papers authored by Jingyao Zhang
This map shows the geographic impact of Jingyao Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingyao Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingyao Zhang more than expected).
Fields of papers citing papers by Jingyao Zhang
This network shows the impact of papers produced by Jingyao Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingyao Zhang. The network helps show where Jingyao Zhang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jingyao Zhang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 3 | |
| 6 | 2023 | 15 | |
| 7 | 2023 | 4 | |
| 8 | 2023 | 5 | |
| 9 | 2023 | 17 | |
| 10 | 2023 | 5 | |
| 11 | 2023 | 4 | |
| 12 | 2023 | 12 | |
| 13 | 2022 | 7 | |
| 14 | 2022 | 45 | |
| 15 | 2022 | 13 | |
| 16 | 2021 | 46 | |
| 17 | 2021 | 21 | |
| 18 | 2021 | 36 | |
| 19 | 2019 | 8 | |
| 20 | 2016 | 7 |
About Jingyao Zhang
Jingyao Zhang is a scholar working on Hepatology, Cancer Research and Critical Care and Intensive Care Medicine, having authored 186 papers that have together received 4.3k indexed citations. Recurring topics across this work include RNA modifications and cancer (17 papers), Liver Disease Diagnosis and Treatment (14 papers), Hydrogen's biological and therapeutic effects (12 papers), Cancer-related molecular mechanisms research (12 papers), Epigenetics and DNA Methylation (11 papers), Hepatocellular Carcinoma Treatment and Prognosis (10 papers), Sepsis Diagnosis and Treatment (10 papers) and Liver Disease and Transplantation (9 papers). The work is most often cited by research in Cancer Research (697 citations), Hepatology (325 citations) and Molecular Biology (2.1k citations). Jingyao Zhang has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Kai Qu, Ruixia Cui, Yifan Jia, Jianbin Bi, Chang Liu, Runchen Miao, Sushun Liu, Yang Feng, Yingmu Tong and Jingxian Gu. Their work appears in journals such as Journal of Clinical Investigation, Nature Immunology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.